investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Study of Structures of CCR5 and Its Interactions with CCR5 Inhibitors
Hiroaki Mitsuya
2 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Hiromi Ogata-Aoki
Kumamoto University
Kumamoto, Japan
Hiroaki Mitsuya
National Cancer Institute (NIH)
Rockville, United States
Yoshikazu Takaoka
Ono Pharmaceutical Co. Ltd.
Osaka, Japan
Related projects
Zhimin Lu
Deciphering the role of Cdc25A in cancer metabolism.
All cancers but non-melanoma skin cancer
Federico Bernal
Broadening the Utility of Stapled Peptides through Chemical Optimization
All cancers but non-melanoma skin cancer
Radiation Oncology
Jordan Scott Orange
Directing Function at the Natural Killer Cell Secretory Immunological Synapse
All cancers but non-melanoma skin cancer
Jerald Patrick Radich
Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer
All cancers but non-melanoma skin cancer
Peter Blumberg
Molecular Mechanism of Action of Phorbol Ester – Rockville
All cancers but non-melanoma skin cancer
Alexander Gimelbrant
(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect
All cancers but non-melanoma skin cancer
Frank Maldarelli
HIV Persistence During Suppressive Antiretroviral Therapy
All cancers but non-melanoma skin cancer
Gordon B. Mills
Biological annotation of TCGA data
All cancers but non-melanoma skin cancer
Augustin Luna
Chemogenomic Analysis of the NCI Therapeutic Compound Database
All cancers but non-melanoma skin cancer